Clearmind Medicine

CMND

Biotechnology · Healthcare

Price

$1.94

-0.05 (-2.51%)

Market Cap

$2.0M

Exchange

NASDAQ Capital Market

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+16347.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 8K (2021) → 1.3M (2025)

Clearmind Medicine Inc. is a small biotechnology company focused on developing psychedelic-based medicines to treat mental health conditions. Its main area of research involves compounds related to MDMA and other psychedelic substances, targeting disorders like alcohol use disorder and obesity. The company is in early-stage drug development and does not yet sell any approved products.

Clearmind generates no commercial revenue at this stage, as it is a pre-revenue clinical-stage company spending money on research and development. It is based in Canada and is a very small operation, reflected in its near-zero market cap and deeply negative returns on capital. The biggest risk the company faces is the long, expensive, and uncertain path of getting a drug approved by regulators like the FDA, and it will likely need to raise additional cash to continue funding its research.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

-993.5% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$2M/ year

↑ Rising (+49% vs prior year)

R&D investment increasing — building for the future

Insider Activity

25.7%ownership

Insiders own a meaningful stake in the company

Cash Runway

~23 months

$14M cash & investments

Adequate runway but may need to raise capital within 2 years

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

—

Data not available

Operating Margin

N/A

—

Data not available

ROCE

-13.7%

Weak — -13.7% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial